A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients

A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention

(2015) Andrew C. Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes

(2014) Benjamin C. Thompson et al.   EXPERIMENTAL DERMATOLOGY

Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin

(2013) Devita Surjana et al.   CARCINOGENESIS

Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how

(2012) Vincenzo Bettoli et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing

(2011) L. Feldmeyer et al.   BRITISH JOURNAL OF DERMATOLOGY

Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans

(2008) E. Yiasemides et al.   CARCINOGENESIS